Glycosylated extracellular vesicles released by glioblastoma cells are decorated by CCL18 allowing for cellular uptake via chemokine receptor CCR8

ABSTRACT Cancer cells release extracellular vesicles (EVs) that contain functional biomolecules such as RNA and proteins. EVs are transferred to recipient cancer cells and can promote tumour progression and therapy resistance. Through RNAi screening, we identified a novel EV uptake mechanism involving a triple interaction between the chemokine receptor CCR8 on the cells, glycans exposed on EVs and the soluble ligand CCL18. This ligand acts as bridging molecule, connecting EVs to cancer cells. We show that glioblastoma EVs promote cell proliferation and resistance to the alkylating agent temozolomide (TMZ). Using in vitro and in vivo stem-like glioblastoma models, we demonstrate that EV-induced phenotypes are neutralised by a small molecule CCR8 inhibitor, R243. Interference with chemokine receptors may offer therapeutic opportunities against EV-mediated cross-talk in glioblastoma.

[1]  R. Markwald,et al.  Chapter 1 Introduction to COVID-19 , 2022, COVID-19 in the Environment.

[2]  Hakho Lee,et al.  MicroRNA Signatures and Molecular Subtypes of Glioblastoma: The Role of Extracellular Transfer , 2017, Stem cell reports.

[3]  F. Wendler,et al.  Extracellular vesicles swarm the cancer microenvironment: from tumor–stroma communication to drug intervention , 2017, Oncogene.

[4]  T. Lagerweij,et al.  Blocking Tumor-Educated MSC Paracrine Activity Halts Osteosarcoma Progression , 2017, Clinical Cancer Research.

[5]  M. Bootman,et al.  Exosomes bind to autotaxin and act as a physiological delivery mechanism to stimulate LPA receptor signalling in cells , 2016, Journal of Cell Science.

[6]  J. Meldolesi,et al.  Binding and Fusion of Extracellular Vesicles to the Plasma Membrane of Their Cell Targets , 2016, International journal of molecular sciences.

[7]  Yang Liu,et al.  Bioinformatic profiling identifies an immune-related risk signature for glioblastoma , 2016, Neurology.

[8]  L. Yin,et al.  Exosome-shuttling microRNA-21 promotes cell migration and invasion-targeting PDCD4 in esophageal cancer. , 2016, International journal of oncology.

[9]  J. Adamec,et al.  Identification of Glycoproteins on the Surface of Cow's Milk Exosomes that Mediate the Uptake of Exosomes into Human Colon Carcinoma Caco‐2 Cells , 2016 .

[10]  D. Pegtel,et al.  Extracellular Vesicles Exploit Viral Entry Routes for Cargo Delivery , 2016, Microbiology and Molecular Reviews.

[11]  Tetsuya Yamamoto,et al.  Application of a Persistent Heparin Treatment Inhibits the Malignant Potential of Oral Squamous Carcinoma Cells Induced by Tumor Cell-Derived Exosomes , 2016, PloS one.

[12]  Meng Xu,et al.  The regulation of cancer cell migration by lung cancer cell-derived exosomes through TGF-β and IL-10. , 2016, Oncology letters.

[13]  Wendy W Y Choi,et al.  Exosomes confer pro-survival signals to alter the phenotype of prostate cells in their surrounding environment , 2016, Oncotarget.

[14]  V. Govorun,et al.  Isolation of exosomes by differential centrifugation: Theoretical analysis of a commonly used protocol , 2015, Scientific Reports.

[15]  A. Purushothaman,et al.  Fibronectin on the Surface of Myeloma Cell-derived Exosomes Mediates Exosome-Cell Interactions* , 2015, The Journal of Biological Chemistry.

[16]  Gary K. Schwartz,et al.  Tumour exosome integrins determine organotropic metastasis , 2015, Nature.

[17]  Paloma Martin,et al.  Exosomes enriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer , 2015, Oncotarget.

[18]  R. Lima,et al.  Intercellular Transfer of Cancer Drug Resistance Traits by Extracellular Vesicles. , 2015, Trends in molecular medicine.

[19]  M. Faretta,et al.  Extracellular vesicle-mediated transfer of CLIC1 protein is a novel mechanism for the regulation of glioblastoma growth , 2015, Oncotarget.

[20]  P. Lichter,et al.  Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts. , 2015, Blood.

[21]  Anne Clavreul,et al.  Toward an effective strategy in glioblastoma treatment. Part I: resistance mechanisms and strategies to overcome resistance of glioblastoma to temozolomide. , 2015, Drug discovery today.

[22]  Jacco van Rheenen,et al.  In Vivo Imaging Reveals Extracellular Vesicle-Mediated Phenocopying of Metastatic Behavior , 2015, Cell.

[23]  X. Breakefield,et al.  Heparin affinity purification of extracellular vesicles , 2015, Scientific Reports.

[24]  Michael A. Hollingsworth,et al.  Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver , 2015, Nature Cell Biology.

[25]  Bob S. Carter,et al.  Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma , 2015, Nature Communications.

[26]  Mark D. Johnson,et al.  Belonging to a network--microRNAs, extracellular vesicles, and the glioblastoma microenvironment. , 2015, Neuro-oncology.

[27]  T. Wurdinger,et al.  Overcoming the blood-brain tumor barrier for effective glioblastoma treatment. , 2015, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[28]  Imre Mäger,et al.  Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting , 2015, Journal of extracellular vesicles.

[29]  J. Redzic,et al.  Examination of the specificity of tumor cell derived exosomes with tumor cells in vitro. , 2014, Biochimica et biophysica acta.

[30]  B. Ylstra,et al.  Nontemplated nucleotide additions distinguish the small RNA composition in cells from exosomes. , 2014, Cell reports.

[31]  Pieter Wesseling,et al.  Identification of temozolomide resistance factors in glioblastoma via integrative miRNA/mRNA regulatory network analysis , 2014, Scientific Reports.

[32]  T. Patel,et al.  Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer , 2014, FEBS open bio.

[33]  Daozhen Chen,et al.  Essential role for TrpC5-containing extracellular vesicles in breast cancer with chemotherapeutic resistance , 2014, Proceedings of the National Academy of Sciences.

[34]  Y. Iwakura,et al.  Chemokine Receptor CCR8 Is Required for Lipopolysaccharide-Triggered Cytokine Production in Mouse Peritoneal Macrophages , 2014, PloS one.

[35]  Ruo-Pan Huang,et al.  Tumor-induced perturbations of cytokines and immune cell networks. , 2014, Biochimica et biophysica acta.

[36]  P. Kuo,et al.  Characterization of Uptake and Internalization of Exosomes by Bladder Cancer Cells , 2014, BioMed research international.

[37]  R. Pink,et al.  Routes and mechanisms of extracellular vesicle uptake , 2014, Journal of extracellular vesicles.

[38]  T. Wurdinger,et al.  EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma , 2013, Oncotarget.

[39]  Nicolas Servant,et al.  A comprehensive evaluation of normalization methods for Illumina high-throughput RNA sequencing data analysis , 2013, Briefings Bioinform..

[40]  E. Tranfield,et al.  Sialoglycoproteins and N-Glycans from Secreted Exosomes of Ovarian Carcinoma Cells , 2013, PloS one.

[41]  Katrin J. Svensson,et al.  Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity , 2013, Proceedings of the National Academy of Sciences.

[42]  W. Shreffler,et al.  Identification of human CCR8 as a CCL18 receptor , 2013, The Journal of experimental medicine.

[43]  X. Breakefield,et al.  Heparin blocks transfer of extracellular vesicles between donor and recipient cells , 2013, Journal of Neuro-Oncology.

[44]  Pavel Senin,et al.  Comparison of normalization methods for differential gene expression analysis in RNA-Seq experiments , 2013, Communicative & integrative biology.

[45]  Sathish Kumar Mungamuri,et al.  Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses , 2013, The Journal of experimental medicine.

[46]  J. Beijnen,et al.  Targeting core (mutated) pathways of high-grade gliomas: challenges of intrinsic resistance and drug efflux. , 2013, CNS oncology.

[47]  Mattias Belting,et al.  Exosome Uptake Depends on ERK1/2-Heat Shock Protein 27 Signaling and Lipid Raft-mediated Endocytosis Negatively Regulated by Caveolin-1 , 2013, The Journal of Biological Chemistry.

[48]  P. Pu,et al.  miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase. , 2013, Neuro-oncology.

[49]  J. Schellens,et al.  Abcc4 Together with Abcb1 and Abcg2 Form a Robust Cooperative Drug Efflux System That Restricts the Brain Entry of Camptothecin Analogues , 2013, Clinical Cancer Research.

[50]  L. Su,et al.  Expansion of CCR8+ Inflammatory Myeloid Cells in Cancer Patients with Urothelial and Renal Carcinomas , 2013, Clinical Cancer Research.

[51]  L. O’Driscoll,et al.  Docetaxel-Resistance in Prostate Cancer: Evaluating Associated Phenotypic Changes and Potential for Resistance Transfer via Exosomes , 2012, PloS one.

[52]  Yi-rong Wang,et al.  miR-92a is a critical regulator of the apoptosis pathway in glioblastoma with inverse expression of BCL2L11. , 2012, Oncology reports.

[53]  T. Wurdinger,et al.  Extracellular Vesicles and Their Convergence with Viral Pathways , 2012, Advances in virology.

[54]  Geoffrey S. Tobias,et al.  Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer. , 2012, Carcinogenesis.

[55]  Gema Moreno-Bueno,et al.  Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET , 2012, Nature Medicine.

[56]  S. Connolly,et al.  Orally bioavailable allosteric CCR8 antagonists inhibit dendritic cell, T cell and eosinophil migration. , 2012, Biochemical pharmacology.

[57]  B. O'neill,et al.  Glioblastoma survival in the United States before and during the temozolomide era , 2012, Journal of Neuro-Oncology.

[58]  K. Tachibana,et al.  MEK‐ERK Signaling Dictates DNA‐Repair Gene MGMT Expression and Temozolomide Resistance of Stem‐Like Glioblastoma Cells via the MDM2‐p53 Axis , 2011, Stem cells.

[59]  C. Beier,et al.  Chemoresistance of glioblastoma cancer stem cells - much more complex than expected , 2011, Molecular Cancer.

[60]  L. Mahal,et al.  Identification of a conserved glycan signature for microvesicles. , 2011, Journal of proteome research.

[61]  N. Raab-Traub,et al.  Microvesicles and Viral Infection , 2011, Journal of Virology.

[62]  Hamid Cheshmi.  Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers , 2011 .

[63]  S. Wickline,et al.  Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. , 2011, Cancer research.

[64]  Ming Yi,et al.  Human glioma growth is controlled by microRNA-10b. , 2011, Cancer research.

[65]  M. Ewen,et al.  CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. , 2011, Cancer cell.

[66]  M. Braga,et al.  Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer , 2011, The Journal of experimental medicine.

[67]  Jared L. Johnson,et al.  Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells , 2011, Proceedings of the National Academy of Sciences.

[68]  J. van der Oost,et al.  Occurrence of L-iduronic acid and putative D-glucuronyl C5-epimerases in prokaryotes , 2011, Glycoconjugate Journal.

[69]  Sascha Keller,et al.  Interaction and uptake of exosomes by ovarian cancer cells , 2011, BMC Cancer.

[70]  J. Lötvall,et al.  Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages , 2011, Journal of Translational Medicine.

[71]  F. Antunes,et al.  Coreceptor usage by HIV-1 and HIV-2 primary isolates: the relevance of CCR8 chemokine receptor as an alternative coreceptor. , 2010, Virology.

[72]  J. Lustgarten,et al.  Blockade of CCL1 Inhibits T Regulatory Cell Suppressive Function Enhancing Tumor Immunity without Affecting T Effector Responses , 2010, The Journal of Immunology.

[73]  Andrew P. Stubbs,et al.  Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. , 2009, Cancer research.

[74]  A. Molinari,et al.  Microenvironmental pH Is a Key Factor for Exosome Traffic in Tumor Cells* , 2009, The Journal of Biological Chemistry.

[75]  G. Grau,et al.  Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells , 2009, Leukemia.

[76]  E. Domany,et al.  Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[77]  A. Guha,et al.  Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells , 2008, Nature Cell Biology.

[78]  S. Nagata,et al.  Identification of Tim4 as a phosphatidylserine receptor , 2007, Nature.

[79]  M. Christmann,et al.  MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. , 2007, DNA repair.

[80]  A. Mcdonald,et al.  CCR8 Expression Identifies CD4 Memory T Cells Enriched for FOXP3+ Regulatory and Th2 Effector Lymphocytes , 2006, The Journal of Immunology.

[81]  Oliver Hobert,et al.  The molecular diversity of glycosaminoglycans shapes animal development. , 2006, Annual review of cell and developmental biology.

[82]  Jayant P. Menon,et al.  Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. , 2006, Cancer cell.

[83]  Aled Clayton,et al.  Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids , 2006, Current protocols in cell biology.

[84]  K. Kosik,et al.  MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. , 2005, Cancer research.

[85]  T. Handel,et al.  Regulation of protein function by glycosaminoglycans--as exemplified by chemokines. , 2005, Annual review of biochemistry.

[86]  Martin J. van den Bent,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[87]  Finn Drabløs,et al.  Alkylation damage in DNA and RNA--repair mechanisms and medical significance. , 2004, DNA repair.

[88]  J. Renauld,et al.  CCR8‐dependent activation of the RAS/MAPK pathway mediates anti‐apoptotic activity of I‐309/CCL1 and vMIP‐I , 2003, European journal of immunology.

[89]  K. Aldape,et al.  CC chemokine receptor 8 in the central nervous system is associated with phagocytic macrophages. , 2003, The American journal of pathology.

[90]  Ten Feizi,et al.  Oligosaccharide microarrays for high-throughput detection and specificity assignments of carbohydrate-protein interactions , 2002, Nature Biotechnology.

[91]  L. King,et al.  CCR8 on Human Thymocytes Functions as a Human Immunodeficiency Virus Type 1 Coreceptor , 2000, Journal of Virology.

[92]  H. Friedman,et al.  Temozolomide and treatment of malignant glioma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[93]  T. Schwartz,et al.  A Highly Selective Cc Chemokine Receptor (Ccr)8 Antagonist Encoded by the Poxvirus Molluscum Contagiosum , 2000, The Journal of experimental medicine.

[94]  R. Hubbard,et al.  Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. , 1999, Biochemistry.

[95]  A. Trkola,et al.  The CC-Chemokine RANTES Increases the Attachment of Human Immunodeficiency Virus Type 1 to Target Cells via Glycosaminoglycans and Also Activates a Signal Transduction Pathway That Enhances Viral Infectivity , 1999, Journal of Virology.

[96]  A. Trkola,et al.  Genetic Subtype-Independent Inhibition of Human Immunodeficiency Virus Type 1 Replication by CC and CXC Chemokines , 1998, Journal of Virology.

[97]  Virginia Litwin,et al.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 , 1996, Nature.

[98]  Stephen C. Peiper,et al.  Identification of a major co-receptor for primary isolates of HIV-1 , 1996, Nature.

[99]  Paul E. Kennedy,et al.  HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.

[100]  S. Arya,et al.  Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells , 1995, Science.

[101]  S. Arya,et al.  Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. , 1995, Science.

[102]  M. Stevens,et al.  NMR and molecular modeling investigation of the mechanism of activation of the antitumor drug temozolomide and its interaction with DNA. , 1994, Biochemistry.

[103]  L. Kjellén,et al.  Cell-Surface Glycosaminoglycans , 1984 .

[104]  T. Chou,et al.  Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. , 1984, Advances in enzyme regulation.